Transplantation for hilar cholangiocarcinoma

Julie K. Heimbach, Michael G. Haddock, Steven R. Alberts, Scott L. Nyberg, Michael B. Ishitani, Charles B. Rosen, Gregory J. Gores

Research output: Contribution to journalArticle

76 Scopus citations

Abstract

1. Patients with primary sclerosing cholangitis(PSC) have a 8 to 12% risk of developing cholangiocarcinoma (CCA). 2. Cytologic techniques for aneuploidy such as digital image analysis and fluorescence in situ hybridization increase the detection rate for CCA. 3. Survival following resection for CCA is 20% to 40% at 5 years. 4. Survival following liver transplantation for unresectable, perihilar CCAs, mass lesion if present <3 cm, is greater than 80% at 5 years. 5. Patients with intrahepatic CCAs are not eligible for liver transplantation.

Original languageEnglish (US)
Pages (from-to)S65-S68
JournalLiver Transplantation
Volume10
Issue number10 SUPPL. 2
DOIs
StatePublished - Oct 1 2004

ASJC Scopus subject areas

  • Surgery
  • Hepatology
  • Transplantation

Fingerprint Dive into the research topics of 'Transplantation for hilar cholangiocarcinoma'. Together they form a unique fingerprint.

  • Cite this